Published in Ann Dermatol Venereol on January 01, 1995
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol (2007) 2.85
Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol (1999) 2.34
High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma. Arch Dermatol (1995) 2.00
The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol (2001) 1.79
Chronic radiodermatitis following cardiac catheterisation: a report of two cases and a brief review of the literature. Heart (1999) 1.78
Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis. J Virol (1984) 1.78
Leg ulcers and hydroxyurea: forty-one cases. Arch Dermatol (1999) 1.77
Schönlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases. Arch Dermatol (1997) 1.76
Comparison of the capsular response to the Biocell RTV and Mentor 1600 Siltex breast implant surface texturing: a scanning electron microscopic study. Plast Reconstr Surg (2001) 1.70
Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol (1996) 1.58
Neutrophilic dermatoses during granulocytopenia. Arch Dermatol (1995) 1.56
A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol (2002) 1.52
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
The reconstitution of living skin. J Invest Dermatol (1983) 1.49
[Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients]. Ann Dermatol Venereol (2003) 1.47
Evidence of a marked 25-hydroxyvitamin D deficiency in patients with congenital ichthyosis. J Eur Acad Dermatol Venereol (2006) 1.45
Short- and medium-term efficacy of specific hydrotherapy in inherited ichthyosis. Br J Dermatol (2011) 1.44
Cyclosporin A inhibits the antigen-presenting functions of freshly isolated human Langerhans cells in vitro. J Invest Dermatol (1991) 1.44
Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch Dermatol (1997) 1.43
Pityriasis rubra pilaris in a patient with human immunodeficiency virus infection. J Am Acad Dermatol (1992) 1.43
Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet (2000) 1.42
[Epidemiological survey of leprosy conducted in metropolitan France between 2009 and 2010]. Ann Dermatol Venereol (2013) 1.41
[Thalidomide and thrombosis]. Ann Dermatol Venereol (2000) 1.40
Acral persistent papular mucinosis and IgA monoclonal gammopathy: report of a case. Dermatology (1992) 1.38
[Bullous pemphigoid-multiple sclerosis association. A case report]. Ann Dermatol Venereol (1990) 1.37
Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene. J Clin Invest (1992) 1.29
Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer (2000) 1.29
Study of 39 documented relapses of multibacillary leprosy after treatment with rifampin. Int J Lepr Other Mycobact Dis (1989) 1.28
Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol (1984) 1.28
Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol (1996) 1.28
A homozygous insertion-deletion in the type VII collagen gene (COL7A1) in Hallopeau-Siemens dystrophic epidermolysis bullosa. Nat Genet (1993) 1.25
Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest (1991) 1.23
Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol (1991) 1.21
Autosomal recessive lamellar ichthyosis: identification of a new mutation in transglutaminase 1 and evidence for genetic heterogeneity. Hum Mol Genet (1995) 1.20
Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science (1985) 1.18
Mapping of Papillon-Lefevre syndrome to the chromosome 11q14 region. Eur J Hum Genet (1997) 1.13
Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells. Eur J Biochem (1994) 1.12
Recurrent nonsense mutations within the type VII collagen gene in patients with severe recessive dystrophic epidermolysis bullosa. Am J Hum Genet (1994) 1.10
Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study. Br J Dermatol (2007) 1.08
Cell survival and shuttle vector mutagenesis induced by ultraviolet A and ultraviolet B radiation in a human cell line. J Invest Dermatol (1996) 1.07
Non-coherent near infrared radiation protects normal human dermal fibroblasts from solar ultraviolet toxicity. J Invest Dermatol (1998) 1.06
HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol (2001) 1.04
UVA-induced lipid peroxidation in cultured human fibroblasts. Biochim Biophys Acta (1991) 1.03
Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nat Genet (1994) 1.02
A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. Br J Dermatol (2007) 1.02
Hypohidrotic ectodermal dysplasia. Clinical study of a family of 30 over three generations. Hum Genet (1989) 1.01
The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils. FEBS Lett (1995) 1.00
T-cell receptor-gamma/delta bearing lymphocytes in normal and inflammatory human skin. J Invest Dermatol (1990) 0.99
Physicochemical properties and stability of anthralin in model systems and human skin. J Invest Dermatol (1983) 0.99
Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense. J Immunol (1997) 0.99
Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. Br J Dermatol (2009) 0.99
Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer (2000) 0.98
Prenatal diagnosis in a subset of trichothiodystrophy patients defective in DNA repair. Br J Dermatol (1992) 0.98
Different papillomaviruses as the causes of oral warts. Arch Dermatol (1982) 0.98
Familial occurrence of KID (keratitis, ichthyosis, deafness) syndrome. Case reports of a mother and daughter. J Am Acad Dermatol (1990) 0.97
Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. J Natl Cancer Inst (2000) 0.96
The contractility of fibroblasts in a collagen lattice is reduced by corticosteroids. J Invest Dermatol (1984) 0.96
[Deep lupus erythematosus in children]. Ann Dermatol Venereol (1992) 0.96
What is the best way to define the antimelanocyte T cell repertoire? J Invest Dermatol (1999) 0.96
Cellular events leading to blister formation in bullous pemphigoid. Br J Dermatol (1980) 0.96
Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins. J Photochem Photobiol B (1990) 0.95
Two new loci for autosomal recessive ichthyosis on chromosomes 3p21 and 19p12-q12 and evidence for further genetic heterogeneity. Am J Hum Genet (2000) 0.95
[Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)]. Ann Dermatol Venereol (2008) 0.94
Mapping of a second locus for lamellar ichthyosis to chromosome 2q33-35. Hum Mol Genet (1996) 0.94
A new method for studying epidermalization in vitro. Br J Dermatol (1986) 0.93
Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. Blood (1981) 0.93
[Painful bruising syndrome mimicking cellulitis of the leg]. Ann Dermatol Venereol (2002) 0.93
P16 UV mutations in human skin epithelial tumors. Oncogene (1999) 0.92
[Pyogenic granuloma of the tongue in chronic graft versus host disease]. Ann Dermatol Venereol (1996) 0.92
Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lefèvre syndrome. J Invest Dermatol (2001) 0.92
Human eosinophils in culture undergo a striking and rapid shrinkage during apoptosis. Role of K+ channels. J Leukoc Biol (1995) 0.92
Bullous and non-bullous ichthyosiform erythroderma associated with generalized pustular psoriasis of von Zumbusch type. Br J Dermatol (2001) 0.92
Ultraviolet A-induced lipid peroxidation and antioxidant defense systems in cultured human skin fibroblasts. J Invest Dermatol (1993) 0.92
Localization of proteolytic activity in psoriatic skin. Br J Dermatol (1982) 0.91
[Methotrexate-induced skin detachment]. Presse Med (1992) 0.91
Prenatal diagnosis of Harlequin fetus. Lancet (1983) 0.91
Neutrophil studies in psoriatics: in vivo migration, phagocytosis and bacterial killing. J Invest Dermatol (1982) 0.90
Inhibition of neutrophil migration by etretinate and its main metabolite. Br J Dermatol (1982) 0.90
Cantharide acantholysis: endogenous protease activation leading to desmosomal plaque dissolution. Br J Dermatol (1988) 0.90
[Erysipelas-like dermatitis of the legs revealing aspergilloma of the maxillary sinus]. Ann Dermatol Venereol (2007) 0.90
Progressive symmetric erythrokeratodermia. Histological and ultrastructural study of patient before and after treatment with etretinate. Arch Dermatol (1986) 0.90
HLA-G expression in atopic dermatitis. J Invest Dermatol (2001) 0.90
Membrane damage induced in cultured human skin fibroblasts by UVA irradiation. Photochem Photobiol (1993) 0.90
Skin manifestations of cardio-facio-cutaneous syndrome. J Am Acad Dermatol (1993) 0.89
Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression. J Clin Invest (1994) 0.89
Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma. Br J Dermatol (1993) 0.89
Unusual specific cutaneous lesions in myelodysplastic syndromes. J Am Acad Dermatol (1995) 0.89
Influence of human dermal fibroblasts on epidermalization. J Invest Dermatol (1989) 0.89
[Cutaneous revelation of Rosai-Dorfman disease: 7 cases]. Ann Dermatol Venereol (2012) 0.89
DNA-based prenatal diagnosis of generalized recessive dystrophic epidermolysis bullosa in six pregnancies at risk for recurrence. J Invest Dermatol (1995) 0.88